Comment on

• Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.

  Herrak P, Görtz B, Hayer S, Redlich K, Reiter E, Gasser J, Bergmeister H, Kollias G, Smolen JS, Schett G. Herrak P, et al. Arthritis Rheum. 2004 Jul;50(7):2327-37. doi: 10.1002/art.20384. Arthritis Rheum. 2004. PMID: 15248234
• Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis.

  Sims NA, Green JR, Glatt M, Schlict S, Martin TJ, Gillespie MT, Romas E. Sims NA, et al. Arthritis Rheum. 2004 Jul;50(7):2338-46. doi: 10.1002/art.20382. Arthritis Rheum. 2004. PMID: 15248235